|
|
Volumn 16, Issue 2, 2002, Pages 92-98
|
|
Implications of matrix effects in ultra-fast gradient or fast isocratic liquid chromatography with mass spectrometry in drug discovery
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG PRODUCTS;
MASS SPECTROMETRY;
RISK ASSESSMENT;
ANALYTES;
BIOLOGICAL MATRIXES;
BIOLOGICAL SAMPLES;
DRUG DISCOVERY;
ISOCRATIC;
MATRICES EFFECT;
MATRIX;
MATRIX COMPONENTS;
RAPID ANALYSIS;
ULTRA-FAST;
LIQUID CHROMATOGRAPHY;
DRUG VEHICLE;
GLUCURONIDE;
MACROGOL;
NEW DRUG;
ANIMAL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BILE;
BLOOD;
CHEMISTRY;
COMPLEX FORMATION;
CONTROLLED STUDY;
DRUG SCREENING;
FLOW RATE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
LABORATORY DIAGNOSIS;
LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
METHODOLOGY;
NONHUMAN;
PHASE SEPARATION;
PHASE TRANSITION;
QUALITY CONTROL;
QUANTITATIVE ASSAY;
RAT;
SIGNAL NOISE RATIO;
TANDEM MASS SPECTROMETRY;
URINE;
ANIMAL;
BILE;
BLOOD;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CHROMATOGRAPHY, LIQUID;
DRUGS, INVESTIGATIONAL;
QUALITY CONTROL;
RATS;
SPECIMEN HANDLING;
SPECTRUM ANALYSIS, MASS;
URINE;
|
|
EID: 0036006585
PISSN: 09514198
EISSN: None
Source Type: Journal
DOI: 10.1002/rcm.544 Document Type: Article |
|
Times cited : (73)
|
|
References (9)
|
